| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.1 |